taxonomy (7)
protein (140)
source (34)
structure (26)
composition (1)
disease (10)
reference (30)
site (175)
peptide (165)
- Homo sapiens (Human)
- Bos taurus (Bovine)
- Hybrid - homo sapiens/mus musculus (Hybrid - human/mouse)
- Mus musculus (House mouse)
- Rattus norvegicus (Norway rat)
- Sus scrofa (Pig)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens P30533
- Anoctamin-6 / Homo sapiens Q4KMQ2
- Antithrombin-III / Homo sapiens P01008
- Apolipoprotein D / Homo sapiens P05090
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens P98160
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Calbindin / Homo sapiens P05937
- Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens P06731
- CD276 antigen / Homo sapiens Q5ZPR3
- CD59 glycoprotein / Homo sapiens P13987
- Ceruloplasmin / Homo sapiens P00450
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens Q11201
- Coagulation factor XIII B chain / Homo sapiens P05160
- Collagen alpha-1(VI) chain / Homo sapiens P12109
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Collagen alpha-2(VI) chain / Homo sapiens P12110
- Collagen alpha-3(VI) chain / Homo sapiens P12111
- Complement component C9 / Homo sapiens P02748
- Complement factor b / Homo sapiens P00751
- Complement factor h / Homo sapiens P08603
- Complement factor H-related protein 1 / Homo sapiens Q03591
- Decorin / Homo sapiens P07585
- Desmocollin-2 / Homo sapiens Q02487
- Dipeptidyl peptidase 1 / Homo sapiens P53634
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens P78536
- DNA-dependent protein kinase catalytic subunit / Homo sapiens P78527
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens Q8TCJ2
- Fibrillin-1 / Homo sapiens P35555
- Fibrinogen beta chain / Homo sapiens P02675
- Fibrinogen gamma chain / Homo sapiens P02679
- Fibromodulin / Homo sapiens Q06828
- Fibronectin / Homo sapiens P02751
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Histidine-rich glycoprotein / Homo sapiens P04196
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin J chain / Homo sapiens P01591
- Integrin alpha-1 / Homo sapiens P56199
- Integrin alpha-2 / Homo sapiens P17301
- Integrin alpha-6 / Homo sapiens P23229
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens Q06033
- Interleukin-1 receptor accessory protein / Homo sapiens Q9NPH3
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-4 / Homo sapiens Q16363
- Laminin subunit alpha-5 / Homo sapiens O15230
- Laminin subunit gamma-1 / Homo sapiens P11047
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens Q14767
- Lysosome membrane protein 2 / Homo sapiens Q14108
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Mannan-binding lectin serine protease 1 / Homo sapiens P48740
- Mimecan / Homo sapiens P20774
- Niemann-Pick C1 protein / Homo sapiens O15118
- Olfactomedin-like protein 3 / Homo sapiens Q9NRN5
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens Q96AY3
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens Q02809
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Protein AMBP / Homo sapiens P02760
- Protein disulfide-isomerase A2 / Homo sapiens Q13087
- Prothrombin / Homo sapiens P00734
- Reticulocalbin-1 / Homo sapiens Q15293
- Secretogranin-3 / Homo sapiens Q8WXD2
- Serotransferrin / Homo sapiens P02787
- Sparc / Homo sapiens P09486
- Tetraspanin-3 / Homo sapiens O60637
- Thrombospondin-1 / Homo sapiens P07996
- Thrombospondin-2 / Homo sapiens P35442
- Translocon-associated protein subunit alpha / Homo sapiens P43307
- Uromodulin / Homo sapiens P07911
- Vitronectin / Homo sapiens P04004
- Von willebrand factor / Homo sapiens P04275
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Collagen alpha-1(IV) chain / Bos taurus Q7SIB2
- Collagen alpha-2 (IV) chain / Bos taurus Q7SIB3
- Ribonuclease, brain / Bos taurus P39873
- Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Cadherin-10 / Mus musculus P70408
- Cadherin-13 / Mus musculus Q9WTR5
- Carbonic anhydrase-related protein 10 / Mus musculus P61215
- Carboxypeptidase D / Mus musculus O89001
- Carboxypeptidase M / Mus musculus Q80V42
- Cell adhesion molecule 4 / Mus musculus Q8R464
- Contactin-1 / Mus musculus P12960
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus Q9Z218
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus P63137
- Golgi apparatus protein 1 / Mus musculus Q61543
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus Q8R3H7
- Immunoglobulin superfamily member 8 / Mus musculus Q8R366
- Integrin beta-2 / Mus musculus P11835
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus Q9R1V6-16
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus Q8BLQ9-2
- Leukocyte surface antigen CD47 / Mus musculus Q61735
- Myelin-oligodendrocyte glycoprotein / Mus musculus Q61885
- Nectin-1 / Mus musculus Q9JKF6
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Neurofascin / Mus musculus A0A087WPX3
- Neuroplastin / Mus musculus P97300
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus Q91ZX7
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus Q64487
- Signal-regulatory protein alpha / Mus musculus P97797
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus P14231
- SPARC / Mus musculus P07214
- SPARC-like protein 1 / Mus musculus P70663
- Tetraspanin-2 / Mus musculus Q922J6
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein / Mus musculus
- Uncharacterized protein from Ascitic fluid / Mus musculus
- Zinc transporter ZIP10 / Mus musculus Q6P5F6
- Uncharacterized protein / Rattus norvegicus
- Amiloride-sensitive amine oxidase / Sus scrofa Q9TRC7
- Coagulation factor VIII / Sus scrofa P12263
- Major seminal plasma glycoprotein psp-i / Sus scrofa P35495
- Major seminal plasma glycoprotein psp-ii / Sus scrofa P35496
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Ascitic fluid (UBERON_0007795) EL4 (CVCL_0255)
- Ascitic fluid (UBERON_0007795)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Cerebellum (UBERON_0002037)
- Colon (UBERON_0001155)
- Frontal Cortex (UBERON_0001870)
- Glomerular Basement Membrane (UBERON_0005777)
- Hippocampul formation (UBERON:0002421)
- Kidney (UBERON_0002113)
- Liver (UBERON_0002107)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Prefrontal Cortex (UBERON:0000451)
- Seminal Fluid (UBERON_0006530)
- Striatum (UBERON_0002345)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
- BW5147 (CVCL_3896) T-Lymphocyte (CL_0000084)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- J558L (CVCL_3949)
- LS174T (CVCL_1384)
- WEHI-231 (CVCL_0577) B-Lymphocyte (CL_0000236)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- B-Lymphocyte (CL_0000236)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
- EBV-transformed B-cell (CL_0000236)
- Erythrocyte (CL_0000232) Plasma Membrane (GO_0005886)
- T-Lymphocyte (CL_0000084)
- Plasma Membrane (GO_0005886)
Source
- Free / Lactose / [Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)][Gal(b1-3)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / [Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-6)][[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)]Gal(b1-4)Glc(b1-
- Free / Lactose / Structure 9159
- Free / Lactose / Structure 9160
- Free / Lactose / Structure 9206
- Free / Lactose / Structure 10860
- Free / Lactose / Structure 10867
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9601
- N-Linked / Complex / Structure 9677
- N-Linked / Hybrid / Structure 9381
- N-Linked / Hybrid / Structure 9910
- N-Linked / Hybrid / Structure 10008
- N-Linked / Hybrid / Structure 10289
- N-Linked / Hybrid / Structure 10422
- N-Linked / Hybrid / Structure 10428
- N-Linked / Hybrid / Structure 10537
- N-Linked / Hybrid / Structure 11630
- N-Linked / Hybrid / Structure 11636
- N-Linked / Hybrid / Structure 11909
Reported structure
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
Composition
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
- Lymphoma, Lymphoblastic (DOID:0080147)
- Lymphoma, Thymic (DOID:10146)
- Myeloma (DOID:0070004)
- Prostate cancer (DOID:10283)
Disease
- Mammalian brain glycoproteins exhibit diminished glycan complexity compared to other tissues (2022 - Williams SE, Noel M, Lehoux S, Cetinbas M, Xavier RJ, Sadreyev RI, Scolnick EM, Smoller JW, Cummings RD, Mealer RG) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena DomÃnguez-Vega) / Status : Reviewed
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- N-Glycosylation in isolated rat nerve terminals (2021 - Matthies I, Abrahams JL, Jensen P, Oliveira T, Kolarich D, Larsen MR) / Status : Reviewed
- Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis. (2020 - Katherine Wongtrakul-Kish, Benjamin R Herbert, Nicolle H Packer) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Spatial and temporal diversity of glycome expression in mammalian brain (2020 - Lee J, Ha S, Kim M, Kim SW, Yun J, Ozcan S, Hwang H, Ji IJ, Yin D, Webster MJ, Shannon Weickert C, Kim JH, Yoo JS, Grimm R, Bahn S, Shin HS, An HJ) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
- Synthesis of Asymmetrical Multiantennary Human Milk Oligosaccharides (2017 - Anthony R Prudden, Lin Liu, Chantelle J Capicciotti, Margreet A Wolfert, Shuo Wang, Zhongwei Gao, Lu Meng, Kelley W Moremen, Geert-Jan Boons) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Development of an Annotated Library of Neutral Human Milk Oligosaccharides (2010 - Shuai Wu, Nannan Tao, J Bruce German, Rudolf Grimm, Carlito B Lebrilla) / Status : Reviewed
- N-linked oligosaccharide structures in the diamine oxidase from porcine kidney. (2000 - Huang Y, Mechref Y, Novotny M) / Status : Reviewed
- Structural characterization of the oligosaccharide chains of native and crystallized boar seminal plasma spermadhesin PSP-I and PSP-II glycoforms. (1999 - Nimtz M, Grabenhorst E, Conradt H, Sanz L, Calvete J) / Status : Reviewed
- Neutral N-glycans in adult rat brain tissue--complete characterisation reveals fucosylated hybrid and complex structures (1998 - Chen YJ, Wing DR, Guile GR, Dwek RA, Harvey DJ, Zamze S) / Status : Reviewed
- Structural study of the sugar chains of porcine factor VIII--tissue- and species-specific glycosylation of factor VIII. (1993 - Hironaka T, Furukawa K, Esmon P, Yokota T, Brown J, Sawada S, Fournel M, Kato M, Minaga T, Kobata A) / Status : Reviewed
- Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. (1993 - Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley S, Tyler R, Jefferis R) / Status : Reviewed
- Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. (1992 - Matsui T, Titani K, Mizuochi T) / Status : Reviewed
- Bovine glomerular basement membrane. Location and structure of the asparagine-linked oligosaccharide units and their potential role in the assembly of the 7 S collagen IV tetramer. (1991 - Langeveld J, Noelken M, Hrd K, Todd P, Vliegenthart J, Rouse J, Hudson B) / Status : Reviewed
- Cell type and maturation stage-dependent polymorphism of N-linked oligosaccharides on murine lymphocytes and lymphoma cells. (1991 - Yoshida T, Takahashi N, Nakashima I) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. (1990 - Lund J, Tanaka T, Takahashi N, Sarmay G, Arata Y, Jefferis R) / Status : Reviewed
- The asparagine-linked sugar chains of the glycoproteins in rat erythrocyte plasma membrane--fractionation of oligosaccharides liberated by hydrazinolysis and structural studies of the neutral oligosaccharides. (1982 - Matsumoto A, Yoshima H, Maeda S, Shiraishi N, Kobata A) / Status : Reviewed
Reference
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Calbindin / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- CD276 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- DNA-dependent protein kinase catalytic subunit / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Integrin alpha-1 / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mimecan / Homo sapiens
- Niemann-Pick C1 protein / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Protein disulfide-isomerase A2 / Homo sapiens
- Prothrombin / Homo sapiens
- Reticulocalbin-1 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
-
Von willebrand factor / Homo sapiens
- Undefined site
- Zinc-alpha-2-glycoprotein / Homo sapiens
-
Collagen alpha-1(IV) chain / Bos taurus
- Undefined site
-
Collagen alpha-2 (IV) chain / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
-
Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carbonic anhydrase-related protein 10 / Mus musculus
- Carboxypeptidase D / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Contactin-1 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus
- Golgi apparatus protein 1 / Mus musculus
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Integrin beta-2 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurofascin / Mus musculus
- Neuroplastin / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus
- SPARC / Mus musculus
- SPARC-like protein 1 / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
- Zinc transporter ZIP10 / Mus musculus
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Amiloride-sensitive amine oxidase / Sus scrofa
- Undefined site
-
Coagulation factor VIII / Sus scrofa
- Undefined site
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LELNLTDSENATCLYAK (17aa)
- SVAQNYSSITHLHSIGK (17aa)
- VKGSQGQFPLTQNVTVVEGGTAILTCR (27aa)
- GSQGQFPLTQNVTVVEGGTAILTCR (25aa)
- TAVNCSSDFDACLITK (16aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- ISPGKNATGMEVGWYR (16aa)
- FSNVTWF (7aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DLQSLEDILHQVENK (15aa)
- FNQTMQPIITAQNAIIEDDTYR (22aa)
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- IRNVSDTTKR (10aa)
- IRNVSDTTK (9aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- LSYNVIPLNLTLDNR (15aa)
- TFYWDFYTNR (10aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YHVLHINTTK (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- DAMVGNYTCEVTELSR (16aa)
- VCSNDNKTFDSSCHFFATK (19aa)
- VCSNDNK (7aa)
- LDKEHLVNISGGPMTYSHR (19aa)
- NTTYCSK (7aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- IVNNATNVVIK (11aa)
- TQSLLIVNNATNVVIK (16aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- FGCEIENNR (9aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- YPQDYQFYIQNFTAIPINTVVPPQR (25aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- ACQFNR (6aa)
- VCQDCPIIAPINDTR (15aa)
- VCQDCPLLAPLNDTR (15aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- NQSVPISCCR (10aa)
- GIPDQKVNFTCK (12aa)
- VNFTCK (6aa)
- NGSLFAFR (8aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- YHYNGTIIDGTSFDTSYSK (19aa)
- ACNATNWIEYMFNK (14aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SLTFNETYQDISELVYGAK (19aa)
- NASNMEYR (8aa)
- KNASNMEYR (9aa)
- EQINITIDHR (10aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NPNGTVTVISR (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- NTTGFK (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- VVIHPNYSQVDIGIIK (16aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- FHLANR (6aa)
- CNMINGTDGDSFHPIITK (18aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- IININPNK (8aa)
- VIDLWDLAQSANLTDK (16aa)
- MIENGSISFIPTIR (14aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- LNSSTIK (7aa)
- IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- GNISTEK (7aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- INGTQICPN (9aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- VFNATR (6aa)
- GEVFNATR (8aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- LNITCESSK (9aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- NNLTTYK (7aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- TMVFPVMYLNESVHIDK (17aa)
- AVNITSENLIDDVVSLIR (18aa)
- CLLYPPWDKNFTENDLLVR (19aa)
- NFTENDLLVR (10aa)
- DECWCPANSTGK (12aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- AIPQPQNVTSIIGCTH (16aa)
- ILDQACGTDNQTYASSCHLFATK (23aa)
- GKANSTGTLVITNPTR (16aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- CEGPGVPTVTVHNTTDKRR (19aa)
- CEGPGVPTVTVHNTTDK (17aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- PPANSTMGSK (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- SCVAVTSAQPQNMSR (15aa)
- CQEAINATCK (10aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- TYENGSSVEYR (11aa)
- QVLSYGQNLSFSFR (14aa)
- EVNDTLLVNELK (12aa)
- TTIVDNNTWNNSHIAIVGK (19aa)
- NNSNNFDLNR (10aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- TLNCSGAHVK (10aa)
- INNTHALVSLLQNLNK (16aa)
- ISKINNTHALVSLLQNLNK (19aa)
- GPFEKNCSVQCAGMTLQTIPLK (22aa)
- KVEVEAVNATAVK (13aa)
- GEGNETNNMVITWKPLR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- NMTLFSDLVAEK (12aa)
- NVTAQICIDK (10aa)
- ISAIDNIINHSSMFIK (16aa)
- QMVENFSPNQTK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- VVNSTTGTGEHIR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFVT (8aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- NISQDLEK (8aa)
- NTSPEGWK (8aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- AFINGTGVETVVSADIPNAHGIAVDWVSR (29aa)
- NLQVYNATSNSLTVK (15aa)
- DACGNGTCR (9aa)
- THANGSIK (8aa)
- VDIPQQPMGIIAVANDTNSCEISPCR (26aa)
- MIEAYNITEK (10aa)
- NALQINNTAVGHAL (14aa)
- EAGNITTDGYEIIGK (15aa)
- NASLALSASIGR (12aa)
- QNLTVTDR (8aa)
- TCVSNCTASQFVCK (14aa)
- SLTQGSLIVGDLAPVNGTSQGK (22aa)
- GVTHLNISGLK (11aa)
- LNGTDPIVAADSK (13aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
Mass spectrometry observed peptide
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Increasing the Coverage of a Mass Spectral Library of Milk Oligosaccharides Using a Hybrid-Search-Based Bootstrapping Method and Milks from a Wide Variety of Mammals (2020 - Concepcion Africano Remoroza, Yuxue Liang, Tytus D. Mak, Yuri Mirokhin, Sergey L. Sheetlin, Xiaoyu Yang, Joice V. San Andres, Michael L. Power, and Stephen E. Stein) / Status : Reviewed
- Human milk oligosaccharides as essential tools for basic and application studies on galectins (2018 - Tadasu Urashima, Jun Hirabayashi, Sachiko Sato, Akira Kobata) / Status : Reviewed
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- Free / Lactose
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
-
Von willebrand factor / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Seminal Fluid (UBERON_0006530)
- Major seminal plasma glycoprotein psp-i / Sus scrofa
- Major seminal plasma glycoprotein psp-ii / Sus scrofa
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Blood Plasma (UBERON_0001969)
- Brain (UBERON_0000955)
- Glomerular Basement Membrane (UBERON_0005777)
- J558L (CVCL_3949)
- Myeloma (DOID:0070004)
- Structural study of the sugar chains of porcine factor VIII--tissue- and species-specific glycosylation of factor VIII. (1993 - Hironaka T, Furukawa K, Esmon P, Yokota T, Brown J, Sawada S, Fournel M, Kato M, Minaga T, Kobata A) / Status : Reviewed
- Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. (1993 - Lund J, Takahashi N, Nakagawa H, Goodall M, Bentley T, Hindley S, Tyler R, Jefferis R) / Status : Reviewed
- Bovine glomerular basement membrane. Location and structure of the asparagine-linked oligosaccharide units and their potential role in the assembly of the 7 S collagen IV tetramer. (1991 - Langeveld J, Noelken M, Hrd K, Todd P, Vliegenthart J, Rouse J, Hudson B) / Status : Reviewed
- The structure of the asparagine-linked sugar chains of bovine brain ribonuclease. (1990 - Katoh H, Ohgi K, Irie M, Endo T, Kobata A) / Status : Reviewed
- A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation. (1990 - Lund J, Tanaka T, Takahashi N, Sarmay G, Arata Y, Jefferis R) / Status : Reviewed
-
Collagen alpha-1(IV) chain / Bos taurus
- Undefined site
-
Collagen alpha-2 (IV) chain / Bos taurus
- Undefined site
- Ribonuclease, brain / Bos taurus
-
Immunoglobulin gamma-2 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-2b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3 (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Immunoglobulin gamma-3b (anti-nip antibody) / Hybrid - homo sapiens/mus musculus
- Undefined site
-
Coagulation factor VIII / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Ascitic fluid (UBERON_0007795) EL4 (CVCL_0255)
- BW5147 (CVCL_3896) T-Lymphocyte (CL_0000084)
- WEHI-231 (CVCL_0577) B-Lymphocyte (CL_0000236)
- B-Lymphocyte (CL_0000236)
- T-Lymphocyte (CL_0000084)
- Plasma Membrane (GO_0005886)
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein / Mus musculus
- Undefined site
-
Uncharacterized protein from Ascitic fluid / Mus musculus
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- N-linked oligosaccharide structures in the diamine oxidase from porcine kidney. (2000 - Huang Y, Mechref Y, Novotny M) / Status : Reviewed
- The asparagine-linked sugar chains of the glycoproteins in rat erythrocyte plasma membrane--fractionation of oligosaccharides liberated by hydrazinolysis and structural studies of the neutral oligosaccharides. (1982 - Matsumoto A, Yoshima H, Maeda S, Shiraishi N, Kobata A) / Status : Reviewed
-
Uncharacterized protein / Rattus norvegicus
- Undefined site
-
Amiloride-sensitive amine oxidase / Sus scrofa
- Undefined site
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Complex
(avg mass : 1949.7927)
- Adipocytes (CL_0000136)
- Adipose-derived stem cells (ADSCs) (CL_0000136)
- Differentiated Adipose-derived stem cells (dADSCs) (CL_0000136)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Milk (UBERON_0001913)
- Lactotransferrin / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- KQIGLYPVLVIDSSGYVNPNYTGRI (25aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Adipocytes (CL_0000136)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- VFNATR (6aa)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Control/Healthy
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Leu83Ser) (DOID:0080545)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Colon (UBERON_0001155)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Colon adenocarcinoma (DOID:234)
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- N-Glycosylation in isolated rat nerve terminals (2021 - Matthies I, Abrahams JL, Jensen P, Oliveira T, Kolarich D, Larsen MR) / Status : Reviewed
- Neutral N-glycans in adult rat brain tissue--complete characterisation reveals fucosylated hybrid and complex structures (1998 - Chen YJ, Wing DR, Guile GR, Dwek RA, Harvey DJ, Zamze S) / Status : Reviewed
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Ascitic fluid (UBERON_0007795)
- Colon (UBERON_0001155)
- Liver (UBERON_0002107)
- LS174T (CVCL_1384)
- Colon adenocarcinoma (DOID:234)
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
-
- N-Linked / Hybrid
(avg mass : 1949.7927)
- Cerebellum (UBERON_0002037)
- Frontal Cortex (UBERON_0001870)
- Hippocampul formation (UBERON:0002421)
- Striatum (UBERON_0002345)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Colon (UBERON_0001155)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- BTI-Tn-5B1-4 (CVCL_C190)
- CHO (CVCL_0213)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- LS174T (CVCL_1384)
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Fuc(a1-2)[Gal(a1-3)]Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(a1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Gal(b1-3)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9601
- N-Linked / Complex / Structure 9677
- N-Linked / Hybrid / Structure 9381
- N-Linked / Hybrid / Structure 9910
- N-Linked / Hybrid / Structure 10008
- N-Linked / Hybrid / Structure 10289
- N-Linked / Hybrid / Structure 10422
- N-Linked / Hybrid / Structure 10428
- N-Linked / Hybrid / Structure 10537
- N-Linked / Hybrid / Structure 11630
- N-Linked / Hybrid / Structure 11636
- N-Linked / Hybrid / Structure 11909
- Cancer, breast (DOID:1612)
- Colon adenocarcinoma (DOID:234)
- COVID-19 (DOID:0080600)
- Prostate cancer (DOID:10283)
- Carcinoembryonic antigen glycosylation (2021 - Kolarich D) / Status : Reviewed
- Structural and functional characterization of SARS-CoV-2 RBD domains produced in mammalian cells (2021 - Christoph Gstöttner, Tao Zhang, Anja Resemann, Sophia Ruben, Stuart Pengelley, Detlev Suckau, Tim Welsink, Manfred Wuhrer, Elena DomÃnguez-Vega) / Status : Reviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin receptor-associated protein / Homo sapiens
- Anoctamin-6 / Homo sapiens
- Antithrombin-III / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Basement membrane-specific heparan sulfate proteoglycan core protein / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Calbindin / Homo sapiens
-
Carcinoembryonic antigen-related cell adhesion molecule 5 / Homo sapiens
- Undefined site
- CD276 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Ceruloplasmin / Homo sapiens
- CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 / Homo sapiens
- Coagulation factor XIII B chain / Homo sapiens
- Collagen alpha-1(VI) chain / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Collagen alpha-2(VI) chain / Homo sapiens
- Collagen alpha-3(VI) chain / Homo sapiens
- Complement component C9 / Homo sapiens
- Complement factor b / Homo sapiens
- Complement factor h / Homo sapiens
- Complement factor H-related protein 1 / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Dipeptidyl peptidase 1 / Homo sapiens
- Disintegrin and metalloproteinase domain-containing protein 17 / Homo sapiens
- DNA-dependent protein kinase catalytic subunit / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibromodulin / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Histidine-rich glycoprotein / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Integrin alpha-1 / Homo sapiens
- Integrin alpha-2 / Homo sapiens
- Integrin alpha-6 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain H3 / Homo sapiens
- Interleukin-1 receptor accessory protein / Homo sapiens
- Laminin subunit alpha-4 / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Latent-transforming growth factor beta-binding protein 2 / Homo sapiens
- Lysosome membrane protein 2 / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Mannan-binding lectin serine protease 1 / Homo sapiens
- Mimecan / Homo sapiens
- Niemann-Pick C1 protein / Homo sapiens
- Olfactomedin-like protein 3 / Homo sapiens
- Peptidyl-prolyl cis-trans isomerase FKBP10 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Protein AMBP / Homo sapiens
- Protein disulfide-isomerase A2 / Homo sapiens
- Prothrombin / Homo sapiens
- Reticulocalbin-1 / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Serotransferrin / Homo sapiens
- Sparc / Homo sapiens
- Tetraspanin-3 / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Thrombospondin-2 / Homo sapiens
- Translocon-associated protein subunit alpha / Homo sapiens
- Uromodulin / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Cadherin-10 / Mus musculus
- Cadherin-13 / Mus musculus
- Carbonic anhydrase-related protein 10 / Mus musculus
- Carboxypeptidase D / Mus musculus
- Carboxypeptidase M / Mus musculus
- Cell adhesion molecule 4 / Mus musculus
- Contactin-1 / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Gamma-aminobutyric acid receptor subunit beta-2 / Mus musculus
- Golgi apparatus protein 1 / Mus musculus
- Heparan sulfate 2-O-sulfotransferase 1 / Mus musculus
- Immunoglobulin superfamily member 8 / Mus musculus
- Integrin beta-2 / Mus musculus
- Isoform 14 of Disintegrin and metalloproteinase domain-containing protein 22 / Mus musculus
- Isoform 2 of Cell adhesion molecule 2 / Mus musculus
- Leukocyte surface antigen CD47 / Mus musculus
- Myelin-oligodendrocyte glycoprotein / Mus musculus
- Nectin-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Neurofascin / Mus musculus
- Neuroplastin / Mus musculus
- Prolow-density lipoprotein receptor-related protein 1 / Mus musculus
- Receptor-type tyrosine-protein phosphatase delta / Mus musculus
- Signal-regulatory protein alpha / Mus musculus
- Sodium/potassium-transporting ATPase subunit beta-2 / Mus musculus
- SPARC / Mus musculus
- SPARC-like protein 1 / Mus musculus
- Tetraspanin-2 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Zinc transporter ZIP10 / Mus musculus
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (CHO) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - RBD domain / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LELNLTDSENATCLYAK (17aa)
- SVAQNYSSITHLHSIGK (17aa)
- VKGSQGQFPLTQNVTVVEGGTAILTCR (27aa)
- GSQGQFPLTQNVTVVEGGTAILTCR (25aa)
- TAVNCSSDFDACLITK (16aa)
- VVRPDSEIGERPPEDNQSFQYDHEAFIGK (29aa)
- ISPGKNATGMEVGWYR (16aa)
- FSNVTWF (7aa)
- CSDGWSFDATTLDDNGTMLFFK (22aa)
- CIQANYSIMENGK (13aa)
- QTLFFNGTR (9aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DLQSLEDILHQVENK (15aa)
- FNQTMQPIITAQNAIIEDDTYR (22aa)
- TAFITNFTLTIDGVTYPGNVK (21aa)
- IRNVSDTTKR (10aa)
- IRNVSDTTK (9aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- TAIFPDIIAQGNASIR (16aa)
- LSYNVIPLNLTLDNR (15aa)
- TFYWDFYTNR (10aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YHVLHINTTK (10aa)
- DIVEYYNDSNGSHVIQGR (18aa)
- DAMVGNYTCEVTELSR (16aa)
- VCSNDNKTFDSSCHFFATK (19aa)
- VCSNDNK (7aa)
- LDKEHLVNISGGPMTYSHR (19aa)
- NTTYCSK (7aa)
- DEGDYFCELQVSGANPMSSNK (21aa)
- IVNNATNVVIK (11aa)
- VIDFNCTTSSVSSAIANTK (19aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- FGCEIENNR (9aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- YPQDYQFYIQNFTAIPINTVVPPQR (25aa)
- ARGNGTLITFHSAFQCCGK (19aa)
- ACQFNR (6aa)
- VCQDCPIIAPINDTR (15aa)
- VCQDCPLLAPLNDTR (15aa)
- LNLTTDPK (8aa)
- IYIDHNNITR (10aa)
- NQSVPISCCR (10aa)
- GIPDQKVNFTCK (12aa)
- VNFTCK (6aa)
- NGSLFAFR (8aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- YHYNGTIIDGTSFDTSYSK (19aa)
- ACNATNWIEYMFNK (14aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSAIR (13aa)
- SWPAVGNCSSAL (12aa)
- SLTFNETYQDISELVYGAK (19aa)
- NASNMEYR (8aa)
- KNASNMEYR (9aa)
- EQINITIDHR (10aa)
- LKGEAEYQEIRNPNGTVTVISR (22aa)
- NPNGTVTVISR (11aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- KLNNLTFLYLDHNALESVPLNLPESLR (27aa)
- NTTGFK (6aa)
- CNTAAPMWLNGTHPSSDEGIVSR (23aa)
- VVIHPNYSQVDIGIIK (16aa)
- FEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGR (39aa)
- FHLANR (6aa)
- CNMINGTDGDSFHPIITK (18aa)
- YFYNGTSMACETFQYGGCMGNGNNFVTEK (29aa)
- IGNWSAMPSCK (11aa)
- IININPNK (8aa)
- VIDLWDLAQSANLTDK (16aa)
- MIENGSISFIPTIR (14aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- LNSSTIK (7aa)
- IITNNSQTPIISPQEVVSCSQYAQGCEGGFPYIIAGK (37aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- LHSNNITK (8aa)
- GNISTEK (7aa)
- IGPGEPLELLCNVSGALPPPGR (22aa)
- INGTQICPN (9aa)
- DQSEDDRQHECLNVTQLLK (19aa)
- GEVFNATR (8aa)
- YFFNVSDEAAIIEK (14aa)
- NATDNISK (8aa)
- VQPFNVTQGK (10aa)
- AGIQAFFQVQECNK (14aa)
- KVSCPIMPCSNATVPDGECCPR (22aa)
- VSCPIMPCSNATVPDGECCPR (21aa)
- LNITCESSK (9aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
- NNLTTYK (7aa)
- ANYTILK (7aa)
- GTAGNAIMDGASQIMGENR (19aa)
- YRGTAGNALMDGASQLMGENR (21aa)
- ENITAPGSDSAVFFEQGTTR (20aa)
- TMVFPVMYLNESVHIDK (17aa)
- AVNITSENLIDDVVSLIR (18aa)
- CLLYPPWDKNFTENDLLVR (19aa)
- NFTENDLLVR (10aa)
- DECWCPANSTGK (12aa)
- NYTDCTSEGR (10aa)
- CGIVPVIAENYNK (13aa)
- CGLVPVLAENYNK (13aa)
- IFNIHSGNGSLYTSKPLDR (19aa)
- AIPQPQNVTSIIGCTH (16aa)
- ILDQACGTDNQTYASSCHLFATK (23aa)
- GKANSTGTLVITNPTR (16aa)
- CEGPGVPTVTVHNTTDKRR (19aa)
- CEGPGVPTVTVHNTTDK (17aa)
- CEGPGVPTVTVHNTTDKR (18aa)
- PPANSTMGSK (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- SCVAVTSAQPQNMSR (15aa)
- CQEAINATCK (10aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- TYENGSSVEYR (11aa)
- QVLSYGQNLSFSFR (14aa)
- EVNDTLLVNELK (12aa)
- TTIVDNNTWNNSHIAIVGK (19aa)
- NNSNNFDLNR (10aa)
- QQQHIFGSNVTDCSGNFCIFR (21aa)
- TLNCSGAHVK (10aa)
- INNTHALVSLLQNLNK (16aa)
- ISKINNTHALVSLLQNLNK (19aa)
- GPFEKNCSVQCAGMTLQTIPLK (22aa)
- KVEVEAVNATAVK (13aa)
- GEGNETNNMVITWKPLR (17aa)
- QLSCVANQNGSQADCELGNPFK (22aa)
- NMTLFSDLVAEK (12aa)
- NVTAQICIDK (10aa)
- ISAIDNIINHSSMFIK (16aa)
- QMVENFSPNQTK (12aa)
- ISEENETTCYMGK (13aa)
- VVNSTTGPGEHIR (13aa)
- CDSGFALDSEERNCTDIDECR (21aa)
- VVNSTTGTGEHIR (13aa)
- SPYEMFGDEEVMCLNGNWTEPPQCK (25aa)
- NGTHWFVT (8aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- NISQDLEK (8aa)
- NTSPEGWK (8aa)
- AWGTPCEMCPAVNTSEYK (18aa)
- AFINGTGVETVVSADIPNAHGIAVDWVSR (29aa)
- NLQVYNATSNSLTVK (15aa)
- DACGNGTCR (9aa)
- THANGSIK (8aa)
- VDIPQQPMGIIAVANDTNSCEISPCR (26aa)
- MIEAYNITEK (10aa)
- NALQINNTAVGHAL (14aa)
- EAGNITTDGYEIIGK (15aa)
- NASLALSASIGR (12aa)
- QNLTVTDR (8aa)
- TCVSNCTASQFVCK (14aa)
- SLTQGSLIVGDLAPVNGTSQGK (22aa)
- GVTHLNISGLK (11aa)
- LNGTDPIVAADSK (13aa)
- FGHSPLINLTGGLSHASDVVLYHQHK (26aa)
Source
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Disease
Reference
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Disease
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Disease
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reference
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reference
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)
Source
Reported glycosite
- Free / Lactose
(avg mass : 1949.7927)